All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.
Referral
Contact us about this page
Heart Failure: Investigations and Monitoring
Scope
The commonest cause of heart failure in the UK is coronary artery disease, and many patients have had a myocardial infarction in the past. Therefore we recommend annual monitoring to assess cardiovascular risk factors and renal function.
Out of scope
BNP and NT-proBNP are both useful "rule in" tests for suspected heart failure, but not appropriate for monitoring heart failure in primary care.
Annually
- Blood - Renal, HbA1C, non-HDL cholesterol (non-fasting)
Routine monitoring of digoxin levels is not recommended. A digoxin concentration measured at least 6 hours after the last dose may be useful to confirm a clinical impression of toxicity or non-adherence. Toxicity may occur even when the concentration is within the 'therapeutic range.'
BNP and NT-proBNP are both useful "rule in" tests for suspected heart failure, but not appropriate for monitoring heart failure in primary care.
Evidence
Chronic heart failure: Management of chronic heart failure in adults in primary and secondary care. NICE guidelines [CG108]. Published: August 2010
Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. NICE guideline [CG181]. Published: July 2014.
Pathway Group
This guideline has been signed off by the Pathology Optimisation Clinical Group on behalf of NEW Devon CCG
Publication date: June 2017
